DKMS Africa has registered over 200,000 potential stem cell donors in the past five years, significantly expanding the pool for patients in need. This remarkable achievement, with more than 200,000 potential donors registered through DKMS Africa over the past five years, shows a dedicated effort to address a critical healthcare challenge. While the volume of registered donors, donor searches, and matches is important, the ultimate measure of success for stem cell transplant programs should be the number of clinically eligible patients who actually receive a transplant. This metric, rather than donor registrations alone, should guide decisions concerning budgets, strategic partnerships, and accountability within the South African healthcare system. The measure that should guide budgets, partnerships, and accountability is how many clinically eligible patients ultimately receive a transplant.
The Donor Match Dilemma
A 2025 DKMS study analyzed human leukocyte antigen (HLA) data from 56,961 South African potential donors. These individuals registered with DKMS between 2019 and 2024. The study's findings indicated that black African patients and white patients exhibited comparable matching probabilities when both donors and patients originated from the same population group. This key insight, stemming from the analysis of HLA data from 56,961 South African potential donors registered between 2019 and 2024, suggests that genetic similarity within specific demographic groups is a key factor in successful donor matching for stem cell transplants. The study specifically found that black African and white patients had approximately the same matching probabilities when donors and patients came from the same population group, noting the importance of diverse donor registries.
Systemic and Financial Hurdles
DKMS Africa has established a goal to reach one million registered stem cell donors by 2030. This ambitious target is driven by the potential for significantly improved patient outcomes. Modelling from a recent study indicated that a donor pool of one million registered black African potential donors could provide black African patients with an 80% probability of finding at least one fully matched donor. Achieving such targets, however, faces broader financial and systemic challenges within the continent's healthcare landscape. Development assistance for health to Africa experienced a significant decline, falling from $25.8-billion in 2021 to approximately $13-billion in 2025. This reduction in funding occurs despite Africa bearing roughly 22% of the global burden of disease, while accounting for only 1% of global health expenditure. This disparity shows a critical need for increased investment and more efficient resource allocation to address the continent's health crises, including the provision of life-saving stem cell transplants.
Proposed Pathways to Treatment
Three key reforms have been proposed to enhance the provision of stem cell transplants for South African patients. These proposals aim to address the multifaceted challenges currently impeding access to this vital treatment. The first recommendation focuses on tracking the patient journey and associated funding more reliably, advocating for a "follow the patient and the money" approach. This aims to generate precise data on patient pathways through the healthcare system, from initial diagnosis to post-transplant care, ensuring transparency and accountability in resource utilization. The second proposed reform suggests establishing structured co-funding mechanisms that are activated prior to the transplant stage, ensuring financial support is in place before critical treatment phases. This proactive approach would alleviate financial burdens on patients and healthcare providers, streamlining the process for eligible individuals. The third reform addresses the efficient use of scarce specialist infrastructure, recommending strategies for sharing these resources across borders. These proposals aim to streamline processes, secure funding, and optimize the utilization of existing medical facilities to improve access to stem cell transplants, ultimately increasing the number of clinically eligible patients who receive the life-saving treatment they need.
